Quantum-Si Inc at Jefferies Healthcare Conference Transcript
Thank you very much. I like to thank the organizers for the opportunity to present here at Jefferies today. Before I jump into the presentation, again, just standard forward-looking statements. If you have specific details you're looking for, you can refer to our SEC filings.
So Quantum-Si is the protein sequencing company. Our instrument called Platinum was launched in December of 2022. And this last quarter was our first quarter of commercial sales. It's the world's first next-generation single molecule protein sequencing platform.
We're assembling an amazing team of people from life science leaders such as Illumina, Millipore, or PacBio. Our novel technology called Time Domain Sequencing allows us to sequence peptides at the amino acid level in a massively parallel fashion on a semiconductor chip. It's protected by over 1,000 patents that are issued or pending and was peer reviewed in the journal Science in October of 2022. Importantly, we have a strong cash position, giving us a runway into 2026.
Looking back at our first quarter
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |